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Background
The aim of this study is to assess the possible prognostic
role of age in the risk of relapse in patients operated for
N0 colorectal cancer and if this role is confirmed in a con-
trol population who underwent adjuvant chemotherapy.
Materials and methods
129 patients who underwent radical surgery for N0 col-
orectal cancer were selected and grouped into three age
classes: <65 years, between 65 and 80, >80.
A subpopulation of 44 patients with colorectal cancer
in stage II was selected from the initial group for a com-
parison with a control population consisting of 63
patients who underwent radical surgery and adjuvant
chemotherapy for neoplasms at the same stage.
Results
In the population of 129 patients, the only significant
correlation between age and clinical-pathological fea-
tures is between advanced age (>80yr) and tumor loca-
tion in the right colon (53.7%, p=0.04).
Risk of relapse is related both to depth of tumor inva-
sion (42.9% in stage T4, 6.3% in stage T1, p=0.01) and
advanced age (19.5% in >80yr, 4% in <65yr).
Overall survival (OS) and disease free survival (DFS)
are significantly lower in patients aged over 80 than
the other two classes. This significance is maintained
by stratifying the 129 patients in the two age classes
(<70, >70).
In the multivariate analysis age > 80yr is significantly
correlated with an increased risk of relapse.
Evaluating the control group no significant correlation
between relapse and clinical-pathological features was
detected.
In the multivariate analysis in stage II population,
advanced age doesn’t play any significant prognostic role
in the risk of recurrence, while a reduction in DFS is
related to depth of tumor invasion and the number of
examined lymph nodes (<12).
Conclusions
The negative prognostic role of advanced age in the risk
of relapse that emerges from the first part of the study
is certainly related to the increased fragility of elderly
patients, which might be caused by several pathophysio-
logical factors hypothesized by several Authors, but does
not appear to be a controindication for surgery.
The comparison between only-operated patients and
control ones in stage II neoplasm doesn’ts h o wap r o g -
nostic role for advanced age in the risk of relapse.
This could be attributed to several factors, first of all
the lack of subjects enrolled in the study, because of the
controversial role of age in stage II candidates for adju-
vant chemotherapy.
However we cannot exclude that adjuvant chemother-
apy could affect the role of age as a prognostic factor.
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